The Genetic Approach to Controlling BSE

Help Support CattleToday:

flounder

Well-known member
Joined
Feb 27, 2006
Messages
1,052
Reaction score
5
Location
TEXAS
The Genetic Approach to Controlling BSE

By: David A. Rodger



Stephen Moore was on holiday in his native

Australia back in May 2003, when he received

the telephone call that changed his life. "A Canadian

reporter was on the line asking me to

comment on a case of bovine spongiform encephalopathy

(BSE) in Alberta," says Dr.

Moore "I still don't know how he tracked me

down. There wasn't much I could say because,

of course, this was news to me."

Back in Edmonton, where he is Chair of Bovine

Genomics in the University of Alberta's

Department of Agricultural, Food and Nutritional

Science, Dr. Moore was quickly brought

up to date. He and his research group had

been intimately involved in mapping the bovine

genome and were considered leaders in identifying

and characterizing genes that affect cattle

growth, yield, fat content and meat tenderness.

"There's a genetic component in BSE susceptibility,"

he explains. "You only have to look at

the UK where some animals in a herd came

down with the disease while others didn't.

This was despite their having eaten the same

contaminated feed. What are the genetic factors

that render cattle more susceptible or

more resistant to BSE? The answers will help

us with intervention, diagnosis, and treatment."

In January 2006, the Alberta Prion Research

Institute appointed Dr. Moore its first scientific

director. Dr. Moore also leads PrioNet's Research

Theme I on BSE. He is Principal Investigator

on two APRI-PrioNet co-funded projects ...2



BSE

- one related to BSE and the other to Chronic Wasting

Disease. Other partners include the University of Alberta,

National Microbiology Laboratories - Public

Health Agency of Canada, National Centre for Foreign

Animal Disease - Canadian Food Inspection Agency.

"The only place in the world that has had a statistically

significant number of BSE cases is the UK," he says.

"The number in Canada is, thankfully, too few for genetic

analysis. So, two of my students went to the

Rosslyn Institute in Scotland to extract DNA from the

blood samples gathered from BSE-infected cattle. That

trip was necessary because blood samples are infectious

and can't be brought into Canada, while DNA

samples are harmless and can be imported. We're now

analyzing the DNA."

In late July 2006, another case of BSE was discovered,

involving a 50-month old Alberta dairy cow born long

after Canada's ban on the use of cattle parts in cattle

feed. How close is a test that detects BSE and other

TSEs in live healthy animals? When will we be able to

detect them in live animals as opposed to postmortem?

"Before there can be a valid test - dozens are in trials

now - two issues must be resolved," says Dr. Moore.

"First, it must be easy to collect a sample, and second,

it can't cost too much. If the test costs more than the

animal is worth, it's of little benefit to producers." For

more information visit the Alberta Prion Research

Institute web site at http://www.prioninstitute.ca. •



Coming to terms with Chronic Wasting disease

By: David A. Rodger



PrioNet's Scientific Director, Neil Cashman,

has referred to chronic wasting disease

(CWD) as "the threat in our own backyard."

Indeed, it could be the Transmissible

Spongiform Encephalopathy with the greatest

potential for species devastation. Leading

PrioNet's Theme 2 efforts to understand and

control CWD is Ted Leighton of the Western

College of Veterinary Medicine in Saskatoon.

Dr. Leighton is recognized internationally for

his research into wildlife diseases. So it will

surprise many to discover that he did his

undergraduate work at Cornell University not

in science but in Theatre Arts. "Theatre Arts

had liberal course requirements," he explains,

"enabling me to take natural science, social

science and humanities in a mix that provided

an excellent general education." He received

his veterinary degree from the University of

Saskatchewan in 1979, completed a Ph.D. in

veterinary pathology at Cornell in 1984, and

returned to the University of Saskatchewan

later that year as professor of veterinary

pathology.

Currently Dr. Leighton is Executive Director

of the Canadian Cooperative Wildlife Health

Centre, which is headquartered in Saskatoon.

The organization is a partnership among

Canada's veterinary colleges and government

agencies responsible for wildlife management,

agriculture, and public health. The Centre's

mandate is one of disease surveillance. It has

programs to monitor the occurrence and

spread of such diseases as avian influenza,

West Nile virus, and CWD (since 1997).

CWD on elk farms in Saskatchewan and

Alberta has been eradicated through a

systematic program of culling infected or

exposed animals. Unfortunately, CWD in wild

animals, especially white-tailed and mule deer,

is much harder to deal with. Two years ago,

the Centre brought together international

...2

CWD

experts in CWD, disease monitoring, deer biology, and other specialties to help determine

whether CWD in wild deer in Canada represented a potential crisis. They determined that it

does.

"They told us Canada had a few years to develop its response to CWD," he recalls, "because

this is a slow-moving disease. They recommended that Canada take determined action to

control the disease in wild deer, but warned that there were no proven methods of doing this

and that scientific research carried out in the affected areas would have to guide any effective

response. They emphasized that there would be large social, ecological or economic

consequences for Canada if we do not stop the spread of CWD in wild deer."

Dr. Leighton praises the foresight that led to PrioNet's creation, and the flexibility the network

has been given to deal with a disease that was, until recently, overshadowed by BSE concerns in

Canada. "Our priority with respect to CWD is to learn as much as we can about how it is

transmitted. Only then can we develop a program to contain and eliminate it." •



Coming Together

PrioNet established its Student and

Young Professional Association

(SYPA) at its recent Annual General

Meeting 2006. Joel Watts and Qasim

Khan (University of Toronto) are

SYPA's interim leaders.

SYPA includes graduate students,

post-doctoral fellows, research associates,

and research technicians who

are involved with PrioNet's network

investigators. The purpose of this

association is to organize studentfocused

events; liaise with PrioNet

regarding issues surrounding students

and young professionals; and work

together to capitalize on the different

programs PrioNet has available to

strengthen their research and training

experience.

PrioNet will be implementing a variety

of education and training programs to

facilitate learning exchange and enrich

the experience of students and young

professionals within the network. For

resources such as job postings and

training updates related to students

and young professionals, visit the Education

and Training link at

http://www.prionetcanada.ca. •



PrioNet's Research Projects Related to CWD & BSE

PrioNet Canada will address Canadian prion challenges through its five research themes. The

theme leaders and targeted research projects related to the themes of Bovine Spongiform Encephalopathy

and Chronic Wasting Disease are outlined below:



Research Theme I: Bovine Spongiform Encephalopathy

Theme Leader: Dr. Steven Moore, University of Alberta

Associate Leader: Dr. Mike Belosevic, University of Alberta

Theme Pathologist: Dr. Stefanie Czub, Canadian Food Inspection Agency

A Comprehensive and Comparative Approach to Genetics & Pathobiology of Prion

Disease

Principal Investigator: Dr. Steven Moore, University of Alberta

Co-Investigators:

Dr. John Williams, Parco Tecnologico Padano, Italy

Dr. Michael Coulthart, Public Health Agency of Canada

Dr. Denny Crews, Agriculture & Agri-food Canada

Dr. Stefanie Czub, Canadian Food Inspection Agency

Dr. Michael Heaton, US Department of Agriculture

Prion Inactivation and Environment

Principal Investigator: Dr. Mike Belosevic, University of Alberta

Co-Investigators:

Dr. Norman Neumann, University of Calgary

Dr. Neil Cashman, University of British Columbia

Dr. Daniel Smith, University of Alberta

Dr. Steven Craik, University of Alberta

Dr. Mohamed Gamal El-Din, University of Alberta

Dr. Phillip Fedorak, University of Alberta

Immunoprophylaxis of Bovine Spongiform Encephalopathy

Principal Investigator: Dr. Andrew A. Potter, University of Saskatchewan

Co-Investigators:

Dr. Philip Griebel, University of Saskatchewan

Dr. Scott Napper, University of Saskatchewan

Dr. Lorne Babiuk, University of Saskatchewan

Research Theme II: Chronic Wasting Disease

Theme Leader: Dr. Ted Leighton, University of Saskatchewan

Associate Theme Leader: Dr. Cheryl Waldner, University of Saskatchewan

Sub-Theme Leader (for Scrapie): Dr. Aru Balachandran, Canadian Food Inspection Agency

Factors Affecting Prevalence and Geographic Spread of Chronic Wasting Disease in

Wild Deer in Saskatchewan (Phase I & II)

Principal Investigator: Dr. Trent Bollinger, University of Saskatchewan

Co-Investigators:

Dr. Dave Coltman, University of Alberta

Dr. Ted Leighton, Canadian Cooperative Wildlife Health Centre, University of Saskatchewan

Dr. Francois Messier, University of Saskatchewan

Dr. Cheryl Waldner, Western College of Veterinary Medicine, University of Saskatchewan

A Comparative Approach Examining Host Response to TSE Infection by Serial Analysis

of Gene Expression (microSAGE) in Cervids and Ovids

Principal Investigator: Dr. Stephen Moore, University of Alberta

Co-Investigators:

Dr. Michael Brownstein, J. Craig Venter Institute

Dr. Mike Miller, Wildlife Research Centre, Colorado

Dr. Catherine Graham, Canadian Food Inspection Agency

Dr. Aru Balachandran, Canadian Food Inspection Agency

PrioNet's Research Projects Related to CWD & BSE

PrioNet Canada will address Canadian prion challenges through its five research themes. The

theme leaders and targeted research projects related to the themes of Bovine Spongiform Encephalopathy

and Chronic Wasting Disease are outlined below:

Stay tuned to upcoming

issues of PrioNews as

we feature PrioNet's

three other research

themes:



==================================END



DNA polymorphisms of the prion doppel gene region in four different German
cattle breeds and cows tested positive for bovine spongiform encephalopathy

Journal Mammalian Genome
Publisher Springer New York
ISSN 0938-8990 (Print) 1432-1777 (Online)
Subject Biomedical and Life Sciences and Medicine
Issue Volume 16, Number 11 / November, 2005
DOI 10.1007/s00335-005-0052-9
Pages 884-892
Online Date Saturday, November 12, 2005


N. Balbus1, A. Humeny1, K. Kashkevich1, I. Henz1, C. Fischer2, C.-M. Becker1
and K. Schiebel1

(1) Institut für Biochemie, Emil-Fischer-Zentrum, Universität
Erlangen-Nürnberg, Fahrstrasse 17, 91054 , Erlangen, Germany
(2) Institut für Humangenetik, Universität Heidelberg, Im Neuenheimer Feld
366, 69120, Heidelberg, Germany

Received: 5 April 2005 Accepted: 18 July 2005 Published online: 11
November 2005

Abstract Polymorphisms of the prion protein gene PRNP have been shown to
influence the susceptibility/resistance to prion infections in human and
sheep. In addition, the T174M polymorphism within the flanking prion doppel
gene (PRND) was thought to be involved in susceptibility to sporadic
Creutzfeldt-Jacob disease. To study a possible influence of DNA
polymorphisms of the bovine PRND gene in bovine spongiform encephalopathy
(BSE), previously identified and newly isolated DNA polymorphisms were
genotyped in all available German cattle that tested positive for BSE.
Genotypes and calculated haplotypes were compared with breeding bulls
serving as controls. Analysis of the four major breeds Schwarzbunt (Holstein
Friesian), Rotbunt (Holstein Red), Fleckvieh (Simmental), and Braunvieh
(Swiss Brown) resulted in the isolation of the previously known
polymorphisms R50H and R132Q and two novel synonymous single nucleotide
polymorphisms (SNPs) C4820T and A5063T. Comparative genotype and haplotype
analysis of BSE and control animals revealed a significantly different
distribution of polymorphisms C4815T and R132Q in Fleckvieh animals but not
in the other breeds tested. No association to BSE susceptibility was
detectable for polymorphisms R50H and A5063T.

----------------------------------------------------------------------------
----


K. Schiebel
Email: [email protected]
Phone: 49-9131 85-26206
Fax: 49-9131 85-22485

References secured to subscribers.


http://www.springerlink.com/content/y12 ... abec8&pi=7


Subject: Atypical BSE in Germany-Proof of transmissibility and biochemical
characterization
Date: August 20, 2006 at 3:33 pm PST
Copyright © 2006 Elsevier B.V. All rights reserved.

Atypical BSE in Germany-Proof of transmissibility and biochemical
characterization


A. Buschmanna, A. Gretzschela, A.-G. Biacabeb, K. Schiebelc, C. Coronad, C.
Hoffmanna, M. Eidena, T. Baronb, C. Casaloned and Martin H. Groschupa, ,

aFriedrich-Loeffler-Institut (FLI), Institute for Novel and Emerging
Infectious Diseases, Boddenblick 5a, 17493 Greifswald, Insel Riems, Germany
bAFSSA-Lyon, Unite ATNC, Lyon, France
cInstitut für Biochemie, Universitity Erlangen-Nürnberg, Germany
dCEA, Instituto Zooprofilattico di Turino, Turin, Italy

Received 11 January 2006; revised 23 May 2006; accepted 2 June 2006.
Available online 17 August 2006.



Abstract


Intensive active surveillance has uncovered two atypical German BSE cases in
older cattle which resemble the two different atypical BSE phenotypes that
have recently been described in France (designated H-type) and Italy
(designated L-type or BASE). The H-type is characterized by a significantly
higher molecular size, but a conventional glycopattern of the proteinase K
treated abnormal prion protein (PrPSc), while the L-type PrPSc has only a
slightly lower molecular size and a distinctly different glycopattern. In
this paper we describe the successful transmission of both German atypical
BSE cases to transgenic mice overexpressing bovine PrPC. Upon challenge with
the L-type, these mice developed BSE after a substantially shorter
incubation period than any classical BSE transmission using these mice to
date. In contrast, the incubation period was distinctly prolonged when these
mice were challenged with the H-type. PrPSc accumulated in the brains of
these mice were of the same atypical BSE type that had been used for the
transmission. These atypical cases suggest the possible existence of
sporadic BSE cases in bovines. It is thus feasible that the BSE epidemic in
the UK could have also been initiated by an intraspecies transmission from a
sporadic BSE case.

Keywords: BSE; Cattle; PrPSc; Biochemical differentiation




http://www.sciencedirect.com/



THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 280, NO. 45, pp. 37408–37414, November 11, 2005

© 2005 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in the U.S.A.



Bovine Prion Protein Gene (PRNP) Promoter Polymorphisms

Modulate PRNP Expression and May Be Responsible for

Differences in Bovine Spongiform Encephalopathy

Susceptibility*□S

Received for publication, June 10, 2005, and in revised form, July 20, 2005 Published, JBC Papers in Press, September 1, 2005, DOI 10.1074/jbc.M506361200

Petra Sander‡, Henning Hamann‡, Cord Dro¨gemu¨ ller‡, Kseniya Kashkevich§, Katrin Schiebel§, and Tosso Leeb‡1

From the ‡Institute for Animal Breeding and Genetics, University of Veterinary Medicine, Bu¨nteweg 17p, 30559 Hannover, Germany

and the §Institute for Biochemistry, University of Erlangen-Nu¨rnberg, Fahrstrasse 17, 91054 Erlangen, Germany



The susceptibility of humans to the variant Creutzfeldt-Jakob

disease is greatly influenced by polymorphisms within the human

prion protein gene (PRNP). Similar genetic differences exist in

sheep, in which PRNP polymorphisms modify the susceptibility to

scrapie. However, the known coding polymorphisms within the

bovine PRNP gene have little or no effect on bovine spongiform

encephalopathy (BSE) susceptibility in cattle. We have recently

found a tentative association between PRNP promoter polymorphisms

and BSE susceptibility in German cattle (Sander, P.,

Hamann, H., Pfeiffer, I., Wemheuer, W., Brenig, B., Groschup, M.,

Ziegler, U., Distl, O., and Leeb, T. (2004) Neurogenetics 5, 19–25).A

plausible hypothesis explaining this observation could be that the

bovine PRNP promoter polymorphisms cause changes in PRNP

expression that might be responsible for differences in BSE incubation

time and/or BSE susceptibility. To test this hypothesis, we performed

a functional promoter analysis of the different bovine PRNP

promoter alleles by reporter gene assays in vitro and by measuring

PRNPmRNAlevels in calves with different PRNP genotypes in vivo.

Twovariable sites, a 23-bp insertion/deletion (indel) polymorphism

containing a RP58-binding site and a 12-bp indel polymorphism

containing an SP1-binding site, were investigated. Band shift assays

indicated differences in transcription factor binding to the different

alleles at the two polymorphisms. Reporter gene assays demonstrated

an interaction between the two postulated transcription factors and

lower expression levels of the ins/ins allele compared with the del/del

allele. The in vivo data revealed substantial individual variation of

PRNP expression in different tissues. In intestinal lymph nodes,

expression levels differed between the different PRNP genotypes. ...SNIP...END...TSS
 
why do we care? how many human cases of BSE related illness have been reported in the last few years?
 
Aero":3qn7l6uu said:
why do we care? how many human cases of BSE related illness have been reported in the last few years?


i would have expected nothing less from some. ignorance is bliss is it not?

fact is, human TSE in the USA i.e. sporadic CJD has tripled in the past few years or so i.e. sporadic CJD some of which is of a phenotype of 'unknown' type. the last two mad cows in the USA were of atypical strain, and from there, we have what we call 'friendly fire' from various routes and sources, and believe me, behind closed doors there is much detate about just this.
but i agree, the easy way out is to just ignore it i.e. ;

AERO wrote;

why do we care? how many human cases of BSE related illness have been reported in the last few years?....end


it's like the mad cows, if you dont look, you don't find....tss


SEE STEADY INCREASE IN SPORADIC CJD IN THE USA FROM
1997 TO 2006. SPORADIC CJD CASES TRIPLED, with phenotype
of 'UNKNOWN' strain growing. ...


http://www.cjdsurveillance.com/resource ... eport.html


the ukbsenvcjd only theory is dead in the water now. ...tss


----- Original Message -----
From: Terry S. Singeltary Sr.
To: Bovine Spongiform Encephalopathy
Cc: [email protected] ; [email protected] ; [email protected]
Sent: Monday, August 07, 2006 10:28 AM
Subject: [BLOODCJD] MAD COW BLOOD HUMANS RECALL (these are dime a dozen)


CJD WATCH MESSAGE BOARD
TSS
MAD COW BLOOD HUMANS RECALL (these are dime a dozen)
Mon Aug 7, 2006 10:24
71.248.132.189

PRODUCT
a) Red Blood Cells, Recall # B-1587-6;
b) Cryoprecipitated AHF, Recall # B-1588-6;
c) Recovered Plasma, Recal # B-1589-6
CODE
a), b) and c) Unit: 2016719
RECALLING FIRM/MANUFACTURER
Walter Shepeard Community Blood Center, Inc., Augusta, GA, by facsimile on
March 13, 2003. Firm initiated recall is complete.
REASON
Blood products, which were collected from a donor who may be at increased
risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.
VOLUME OF PRODUCT IN COMMERCE
3 units
DISTRIBUTION
GA and Germany

______________________________
PRODUCT
a) Red Blood Cells Leukocytes Reduced, Recall # B-1590-6;
b) Fresh Frozen Plasma, Recall # B-1591-6
CODE
a) and b) Unit: 2443595
RECALLING FIRM/MANUFACTURER
South Texas Blood and Tissue Center, San Antonio, TX, by facsimile on June
30, 2004. Firm initiated recall is complete.
REASON
Blood products, which were collected from a donor who may be at increased
risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.
VOLUME OF PRODUCT IN COMMERCE
2 units
DISTRIBUTION
TX

______________________________
PRODUCT
a) Red Blood Cells Leukocytes Reduced, Recall # B-1592-6;
b) Fresh Frozen Plasma, Recall # B-1593-6
CODE
a) and b) Unit: 2545596
RECALLING FIRM/MANUFACTURER
South Texas Blood and Tissue Center, San Antonio, TX, by facsimile on
December 14, 2004 and January 3, 2005. Firm initiated recall is complete.
REASON
Blood products, which were collected from a donor who may be at increased
risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.
VOLUME OF PRODUCT IN COMMERCE
2 units
DISTRIBUTION
TX

______________________________

http://www.fda.gov/bbs/topics/enforce/2 ... 00963.html

these usa mad cow blood for humans are a dime a dozen, the come out just
about every week ;

http://disc.server.com/discussion.cgi?d ... JD%20WATCH

http://disc.server.com/discussion.cgi?d ... JD%20WATCH



http://www.bseinquiry.gov.uk/files/yb/1 ... 003001.pdf




8. The Secretary of State has a number of licences. We understand that
the inactivated polio vaccine is no longer being used. There is a stock
of smallpox vaccine. We have not been able to determine the source
material. (Made in sheep very unlikely to contain bovine ingredients).

http://www.bseinquiry.gov.uk/files/yb/1 ... 010001.pdf


http://www.bseinquiry.gov.uk/files/yb/1 ... 011001.pdf


although 176 products do _not_ conform to the CSM/VPC
guidelines.

http://www.bseinquiry.gov.uk/files/yb/1 ... 011001.pdf




TSS



----- Original Message -----
From: "Terry S. Singeltary Sr." <[email protected]>
To: <[email protected]>
Sent: Wednesday, August 30, 2006 10:17 AM
Subject: TSE ADVISORY COMMITTEE MEETING SEPTEMBER 18-19 2006


##################### Bovine Spongiform Encephalopathy
#####################

TSE ADVISORY COMMITTEE MEETING SEPTEMBER 18-19 2006
Wed Aug 30, 2006 08:11
70.110.86.159



Transmissible Spongiform Encephalopathies Advisory Committee
September 18-19, 2006 Meeting


Date and Time:
The meeting will be held on September 18, 2006, 8 a.m. to 4:30 p.m. and
September 19, 2006, 8 a.m. to 1 p.m.

Location:
Holiday Inn Gaithersburg, MD, 2 Montgomery Village Avenue, Gaithersburg, MD
20879

Contact Person:
William Freas, or Rosanna L. Harvey, 301-827-0314, or FDA Advisory Committee
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area),
code 3014512392. Please call the Information Line for up-to-date information
on this meeting.

Agenda:
On September 18, 2006 the Committee will hear updates on the following
topics: United States and worldwide bovine spongiform encephalopathies
(BSE); variant Creutzfeldt-Jakob disease (vCJD) epidemiology and
transfusion-transmission; blood and plasma donor deferral for transfusion in
France since 1980, guidance; FDA's current assessment and plans regarding
the potential exposure to vCJD from an investigational product, FXI, that
was manufactured from UK donor plasma; and a summary of World Heath
Organization Consultation on distribution of infectivity in tissues of
animals and humans with transmissible spongiform encephalopathies. The
Committee will then discuss experimental clearance of transmissible
spongiform encephalopathy infectivity in plasma-derived Factor VIII
products. In the afternoon, the Committee will discuss FDA's risk assessment
for potential exposure to vCJD from human plasma-derived antihemophilic
factor (FVIII) products and potential responses. On September 19, 2006 the
Committee will discuss possible criteria for approval of donor screening
tests for vCJD.

Oral presentations from the public will be scheduled between approximately
10:45 a.m. and 11:15 p.m. and 2:30 p.m. and 3:00 p.m. on September 18, 2006
and between approximately 10:15 a.m. and 11:45 a.m. on September 19, 2006.
Those desiring to make formal oral presentations should notify the contact
person on or before September 11, 2006.



http://www.fda.gov/cber/advisory/tse/tse0906.htm



CJD WATCH MESSAGE BOARD

TSS
Prion infections, blood and transfusions Aguzzi and Glatzel
Sat Jul 8, 2006 12:18
68.238.108.213


Prion infections, blood and transfusions

Adriano Aguzzi* and Markus Glatzel




http://disc.server.com/discussion.cgi?d ... agemark=60





Freas, William

From:

Sent:

To:

Subject:

Terry S. Singeltary Sr. [[email protected]]

Monday, January 08,200l 3:03 PM

[email protected]

CJDIBSE (aka madcow) Human/Animal TSE's--U.S.--Submission To Scientific
Advisors and

Consultants Staff January 2001 Meeting (short version)

Greetings again Dr. Freas and Committee Members,

I wish to submit the following information to the

Scientific Advisors and Consultants Staff

2001 Advisory Committee (short version).



snip...



I am beginning to think that the endless attempt to track

down and ban, potential victims from known BSE Countries

from giving blood will be futile. You would have to ban

everyone on the globe eventually? AS well, I think we

MUST ACT SWIFTLY to find blood test for TSE's,

whether it be blood test, urine test, eyelid test,

anything at whatever cost, we need a test FAST. ,

DO NOT let the incubation time period of these TSEs fool you.

To think of Scrapie as the prime agent to compare CJD,

but yet overlook the Louping-ill vaccine event in 1930's

of which 1000's of sheep where infected by scrapie

from a vaccine made of scrapie infected sheep brains,

would be foolish. I acquired this full text version of the

event which was recorded in the Annual Congress of 1946

National Vet. Med. Ass. of Great Britain and Ireland.

From the BVA and the URL is posted in my (long version).

U.S.A. should make all human/animal TSE's notifiable at all ages,

with requirements for a thorough surveillance and post-mortem

examinations free of charge, if you are serious about eradicating

this horrible disease in man and animal.

There is histopathology reports describing o florid plaques"

in CJD victims in the USA and some of these victims are getting

younger. I have copies of such autopsies, there has to

be more. PLUS, sub-clinical human TSE's will most definitely

be a problem.

THEN think of vaccineCJD in children and the bovine tissues

used in the manufacturing process, think of the FACT that

this agent surviving 6OO*C.

PNAS -- Brown et al. 97 (7): 3418 scrapie agent live at 600*C

Then think of the CONFIDENTIAL documents of what was known of

human/animal TSE and vaccines in the mid to late 8Os, it was all about

depletion of stock, to hell with the kids, BUT yet they knew.



snip...



full text ;



http://www.fda.gov/ohrms/dockets/ac/01/ ... 1s2_09.pdf





EFSA Scientific Report on the Assessment of the Geographical BSE-Risk (GBR)
of the United States of America (USA)
Last updated: 19 July 2005
Adopted July 2004 (Question N° EFSA-Q-2003-083)

Report
Summary
Summary of the Scientific Report

The European Food Safety Authority and its Scientific Expert Working Group
on the Assessment of the Geographical Bovine Spongiform Encephalopathy (BSE)
Risk (GBR) were asked by the European Commission (EC) to provide an
up-to-date scientific report on the GBR in the United States of America,
i.e. the likelihood of the presence of one or more cattle being infected
with BSE, pre-clinically as well as clinically, in USA. This scientific
report addresses the GBR of USA as assessed in 2004 based on data covering
the period 1980-2003.

The BSE agent was probably imported into USA and could have reached domestic
cattle in the middle of the eighties. These cattle imported in the mid
eighties could have been rendered in the late eighties and therefore led to
an internal challenge in the early nineties. It is possible that imported
meat and bone meal (MBM) into the USA reached domestic cattle and leads to
an internal challenge in the early nineties.

A processing risk developed in the late 80s/early 90s when cattle imports
from BSE risk countries were slaughtered or died and were processed (partly)
into feed, together with some imports of MBM. This risk continued to exist,
and grew significantly in the mid 90's when domestic cattle, infected by
imported MBM, reached processing. Given the low stability of the system, the
risk increased over the years with continued imports of cattle and MBM from
BSE risk countries.

EFSA concludes that the current GBR level of USA is III, i.e. it is likely
but not confirmed that domestic cattle are (clinically or pre-clinically)
infected with the BSE-agent. As long as there are no significant changes in
rendering or feeding, the stability remains extremely/very unstable. Thus,
the probability of cattle to be (pre-clinically or clinically) infected with
the BSE-agent persistently increases.






Publication date: 20 August 2004


EFSA Scientific Report on the Assessment of the Geographical BSE-Risk (GBR)
of the United States of America (USA)

Adopted July 2004 (Question N° EFSA-Q-2003-083)


[Last updated 08 September 2004]
[Publication Date 20 August 2004]


http://www.efsa.europa.eu/en/science/ts ... s/573.html





Subject: [Docket No. FSIS-2006-0011] FSIS Harvard Risk Assessment of Bovine
Spongiform Encephalopathy (BSE)


http://www.fsis.usda.gov/OPPDE/Comments ... 0011-1.pdf




[Docket No. 03-025IFA] FSIS Prohibition of the Use of Specified Risk
Materials for Human Food and Requirement for the Disposition of
Non-Ambulatory Disabled Cattle



http://www.fda.gov/ohrms/dockets/docket ... -vol45.pdf




http://www.fda.gov/ohrms/dockets/docket ... -vol40.pdf




THE SEVEN 1/2 SCIENTIST REPORT *** ;-)




http://www.fda.gov/ohrms/dockets/docket ... tach-1.pdf




https://web01.aphis.usda.gov/regpublic. ... enDocument




http://www.fda.gov/ohrms/dockets/docket ... -vol35.pdf




Docket No, 04-047-l Regulatory Identification No. (RIN) 091O-AF46 NEW BSE
SAFEGUARDS (comment submission)



https://web01.aphis.usda.gov/regpublic. ... enDocument





03-025IF 03-025IF-631 Linda A. Detwiler [PDF]


http://www.fsis.usda.gov/OPPDE/Comments ... IF-631.pdf





Specified Risk Materials (SRMs)

I am in full support of the interim final rule which prohibits SRMs from

being included in food for human consumption. In addition to the list of

tissues published in this rule, I am requesting that additional tissues be

added to the list. These would include dura

("sheath") covering the spinal cord and the ENTIRE INTESTINE (from pylorus

to rectum). The scientific justification is provided below. THESE SRMs

should also be prohibited from ANY FDA regulated food or product intended

for human consumption, including but not limited to flavorings, extracts,

etc. ...

Dr. Linda Detwiler comments in full;


http://www.fsis.usda.gov/OPPDE/Comments ... IF-634.pdf




TIP740203/l 0424 CONFIDENTIAL



http://www.mad-cow.org/00/may00_news.html#aaa



TWA LITTLE minute



http://www.bseinquiry.gov.uk/files/yb/1 ... 001001.pdf

http://www.bseinquiry.gov.uk/files/yb/1 ... 010001.pdf

http://www.bseinquiry.gov.uk/files/yb/1 ... 006001.pdf



COMMERCIAL IN CONFIDENCE



http://www.bseinquiry.gov.uk/files/yb/1 ... 005001.pdf

http://www.bseinquiry.gov.uk/files/yb/1 ... 005001.pdf



NOT FOR PUBLICATION



http://www.bseinquiry.gov.uk/files/yb/1 ... 012001.pdf

http://www.bseinquiry.gov.uk/yb/1988/11/04003001.pdf

http://www.bseinquiry.gov.uk/files/yb/1 ... 007001.pdf

http://www.bseinquiry.gov.uk/files/yb/1 ... 007001.pdf

http://www.bseinquiry.gov.uk/files/yb/1 ... 004001.pdf

http://www.bseinquiry.gov.uk/files/yb/1 ... 003001.pdf

http://www.bseinquiry.gov.uk/files/yb/1 ... 001001.pdf

http://www.bseinquiry.gov.uk/files/yb/1 ... 007001.pdf

http://www.bseinquiry.gov.uk/files/yb/1 ... 001001.pdf

http://www.bseinquiry.gov.uk/files/yb/1 ... 011001.pdf



NON-LICENSED HUMAN TISSUE DEVICES WERE NOT COMMERCIALLY AVAILABLE snip... I
was quite prepared to believe in unofficial pituitary hormones, also in the
1970's, whether as described by Dr. Little, or in other circumstances, for
animal use. snip... The fact that there were jars of pituitaries (or
extract) around on shelves is attested by the still potent 1943 pituitaries,
described in Stockell Hartree et al. (J/RF/17/291) which had come from the
lab. at Mill Hill. Having taken the trouble to collect them, they were not
lightly thrown out...



http://www.bseinquiry.gov.uk/files/ws/s467bx.pdf



more on the 1968 medicine act, they forgot to follow



http://www.bseinquiry.gov.uk/files/yb/1 ... 008001.pdf



Draft cover letter to product licence holders (considered by Human and Vet
Medicines including deer)



http://www.bseinquiry.gov.uk/files/yb/1 ... 008001.pdf

http://www.bseinquiry.gov.uk/files/yb/1 ... 011001.pdf



(It was noted with concern that hormone extracts could be manufactured by a
veterinary surgeon for administration to animals under his care without any
Medicines Act Control.)



http://www.bseinquiry.gov.uk/files/yb/1 ... 011001.pdf

http://www.bseinquiry.gov.uk/files/yb/1 ... 011001.pdf

http://www.bseinquiry.gov.uk/files/yb/1 ... 010001.pdf



TWA LITTLE STATEMENT 331

http://www.bseinquiry.gov.uk/files/ws/s331.pdf



snip...



http://www.fda.gov/ohrms/dockets/dailys ... 7-EC-2.htm



RE-Monitoring the occurrence of emerging forms of Creutzfeldt-Jakob

disease in the United States


Email Terry S. Singeltary:


[email protected]



I lost my mother to hvCJD (Heidenhain Variant CJD). I would like to

comment on the CDC's attempts to monitor the occurrence of emerging

forms of CJD. Asante, Collinge et al [1] have reported that BSE

transmission to the 129-methionine genotype can lead to an alternate

phenotype that is indistinguishable from type 2 PrPSc, the commonest

sporadic CJD. However, CJD and all human TSEs are not reportable

nationally. CJD and all human TSEs must be made reportable in every

state and internationally. I hope that the CDC does not continue to

expect us to still believe that the 85%+ of all CJD cases which are

sporadic are all spontaneous, without route/source. We have many TSEs in

the USA in both animal and man. CWD in deer/elk is spreading rapidly and

CWD does transmit to mink, ferret, cattle, and squirrel monkey by

intracerebral inoculation. With the known incubation periods in other

TSEs, oral transmission studies of CWD may take much longer. Every

victim/family of CJD/TSEs should be asked about route and source of this

agent. To prolong this will only spread the agent and needlessly expose

others. In light of the findings of Asante and Collinge et al, there

should be drastic measures to safeguard the medical and surgical arena

from sporadic CJDs and all human TSEs. I only ponder how many sporadic

CJDs in the USA are type 2 PrPSc?


http://www.neurology.org/cgi/eletters/60/2/176#535



LANCET INFECTIOUS DISEASE JOURNAL


Volume 3, Number 8 01 August 2003


Newsdesk


Tracking spongiform encephalopathies in North America


Xavier Bosch

My name is Terry S Singeltary Sr, and I live in Bacliff, Texas. I lost

my mom to hvCJD (Heidenhain variant CJD) and have been searching for

answers ever since. What I have found is that we have not been told the

truth. CWD in deer and elk is a small portion of a much bigger problem.


49-year-old Singeltary is one of a number of people who have remained

largely unsatisfied after being told that a close relative died from a

rapidly progressive dementia compatible with spontaneous

Creutzfeldt-Jakob disease (CJD). So he decided to gather hundreds of

documents on transmissible spongiform encephalopathies (TSE) and

realised that if Britons could get variant CJD from bovine spongiform

encephalopathy (BSE), Americans might get a similar disorder from

chronic wasting disease (CWD)the relative of mad cow disease seen among

deer and elk in the USA. Although his feverish search did not lead him

to the smoking gun linking CWD to a similar disease in North American

people, it did uncover a largely disappointing situation.


Singeltary was greatly demoralised at the few attempts to monitor the

occurrence of CJD and CWD in the USA. Only a few states have made CJD

reportable. Human and animal TSEs should be reportable nationwide and

internationally, he complained in a letter to the Journal of the

American Medical Association (JAMA 2003; 285: 733). I hope that the CDC

does not continue to expect us to still believe that the 85% plus of all

CJD cases which are sporadic are all spontaneous, without route or source.


Until recently, CWD was thought to be confined to the wild in a small

region in Colorado. But since early 2002, it has been reported in other

areas, including Wisconsin, South Dakota, and the Canadian province of

Saskatchewan. Indeed, the occurrence of CWD in states that were not

endemic previously increased concern about a widespread outbreak and

possible transmission to people and cattle.


To date, experimental studies have proven that the CWD agent can be

transmitted to cattle by intracerebral inoculation and that it can cross

the mucous membranes of the digestive tract to initiate infection in

lymphoid tissue before invasion of the central nervous system. Yet the

plausibility of CWD spreading to people has remained elusive.


Part of the problem seems to stem from the US surveillance system. CJD

is only reported in those areas known to be endemic foci of CWD.

Moreover, US authorities have been criticised for not having performed

enough prionic tests in farm deer and elk.


Although in November last year the US Food and Drug Administration

issued a directive to state public-health and agriculture officials

prohibiting material from CWD-positive animals from being used as an

ingredient in feed for any animal species, epidemiological control and

research in the USA has been quite different from the situation in the

UK and Europe regarding BSE.


Getting data on TSEs in the USA from the government is like pulling

teeth, Singeltary argues. You get it when they want you to have it,

and only what they want you to have.


Norman Foster, director of the Cognitive Disorders Clinic at the

University of Michigan (Ann Arbor, MI, USA), says that current

surveillance of prion disease in people in the USA is inadequate to

detect whether CWD is occurring in human beings; adding that, the

cases that we know about are reassuring, because they do not suggest the

appearance of a new variant of CJD in the USA or atypical features in

patients that might be exposed to CWD. However, until we establish a

system that identifies and analyses a high proportion of suspected prion

disease cases we will not know for sure. The USA should develop a

system modelled on that established in the UK, he points out.



Ali Samii, a neurologist at Seattle VA Medical Center who recently

reported the cases of three hunterstwo of whom were friendswho died

from pathologically confirmed CJD, says that at present there are

insufficient data to claim transmission of CWD into humans; adding that

[only] by asking [the questions of venison consumption and deer/elk

hunting] in every case can we collect suspect cases and look into the

plausibility of transmission further. Samii argues that by making both

doctors and hunters more aware of the possibility of prions spreading

through eating venison, doctors treating hunters with dementia can

consider a possible prion disease, and doctors treating CJD patients

will know to ask whether they ate venison.


CDC spokesman Ermias Belay says that the CDC will not be investigating

the [Samii] cases because there is no evidence that the men ate

CWD-infected meat. He notes that although the likelihood of CWD

jumping the species barrier to infect humans cannot be ruled out 100%

and that [we] cannot be 100% sure that CWD does not exist in humans&

the data seeking evidence of CWD transmission to humans have been very

limited.




http://infection.thelancet.com/journal/journal.isa




he complained in a letter to the Journal of the American Medical



Association (JAMA 2003; 285: 733). I hope that the CDC does not

continue to expect us to still believe that the 85% plus of all CJD

cases which are sporadic are all spontaneous, without route or source.<<<



actually, that quote was from a more recent article in the Journal of

Neurology (see below), not the JAMA article...



Full Text

Diagnosis and Reporting of Creutzfeldt-Jakob Disease

Singeltary, Sr et al. JAMA.2001; 285: 733-734.



http://jama.ama-assn.org/cgi/content/fu ... 733?maxtos
how=&HITS=10&hits=10&RESULTFORMAT=&fulltext=dignosing
+and+reporting+creutzfeldt+jakob+disease&searchid=1048865
596978_1528&stored_search=&FIRSTINDEX=0&journalcode=
jama



BRITISH MEDICAL JOURNAL



SOMETHING TO CHEW ON



BMJ



http://www.bmj.com/cgi/eletters/319/7220/1312/b#EL2



BMJ



http://www.bmj.com/cgi/eletters/320/7226/8/b#EL1
 
flounder":3gls8om7 said:
i would have expected nothing less from some. ignorance is bliss is it not?

enjoy your paranoia. maybe you should apply for a news anchor job on Fox News so you can scare a larger audience that knows less.

and after they reject you, find a cause that is meaningful and makes a difference in people's lives or even in your life. if this is the biggest concern you can come up with, you might need to look around your house or in the mirror... the internet and TV have led you astray.
 
Aero":2m5s6v8a said:
flounder":2m5s6v8a said:
i would have expected nothing less from some. ignorance is bliss is it not?

enjoy your paranoia. maybe you should apply for a news anchor job on Fox News so you can scare a larger audience that knows less.

and after they reject you, find a cause that is meaningful and makes a difference in people's lives or even in your life. if this is the biggest concern you can come up with, you might need to look around your house or in the mirror... the internet and TV have led you astray.


FOX NEWS AND OUR FEDERAL GOVERNMENT IS who has led us astray. the transmission studies speak for themselves. you can ignore it all you want, but it's not going away. folks like you will see to that :help:



Report on the monitoring and testing

of ruminants for the presence

of transmissible spongiform

encephalopathy (TSE) in the EU in

2005





In 2005, a total of 10.113.559 bovine, 349.340 ovine and 265.489 caprine animals were

tested in the EU in the framework of the TSE monitoring programme. 561 bovine, 2906 ovine

and 989 caprine animals turned out positive.

1.489.988 risk bovine animals and 8.607.051 healthy animals slaughtered for human consumption

were tested by rapid tests. 2.971 bovine animals were tested in the framework of

passive surveillance (animals reported as BSE suspects by the farmer or the veterinary practitioner

and subject to laboratory examination). In addition, 13.549 animals were tested in the

framework of culling of animals with an epidemiological connection to a BSE case. 87 % of

positive cases were detected by the active monitoring (testing of risk animals, healthy slaughtered

and culled cattle) and 13 % were detected by passive surveillance. BSE cases were found

in all Member States except Cyprus, Estonia, Greece, Hungary, Latvia, Lithuania, Malta, Finland

and Sweden. The number of BSE cases and the overall prevalence in tested animals decreased

by respectively 35 % and 29 % in 2005 compared to 2004. The decrease was similar in both

risk and healthy animals. These reductions and the increasing age of positive cases indicate

that measures taken in the past are having some effect.

346.959 ovine animals were tested by active monitoring, while 2.424 were animals reported

as TSE suspects and therefore subjected to laboratory examination. In caprine animals, the

numbers of tests in the respective groups were 263.921 (active monitoring) and 1.560 (TSE

suspects), 806 and 153 TSE cases in respectively sheep and goats confirmed in 2005 were

subjected to discriminatory testing. Only in 2 sheep BSE could not be excluded by the primary

discriminatory test and further analyses were needed. No new BSE cases in small ruminants

were confirmed in 2005. The results of genotyping TSE positive and random sampled sheep,

provides useful information to evaluate the susceptibility of sheep genotypes to classical and

atypical scrapie.

In addition to the Member States, Bulgaria and Norway forwarded information on the TSE testing

of bovine, ovine and caprine animals.

Further information:

Health and Consumer Protection Directorate-General, Unit E2;

fax: +32-2-296.90.62;

e-mail: [email protected]



http://ec.europa.eu/food/food/biosafety ... 005_en.pdf



"The fact the Texas cow showed up fairly clearly implied the existence of
other undetected cases," Dr. Paul Brown, former medical director of the
National Institutes of Health's Laboratory for Central Nervous System
Studies and an expert on mad cow-like diseases, told United Press
International. "The question was, 'How many?' and we still can't answer
that."

Brown, who is preparing a scientific paper based on the latest two mad cow
cases to estimate the maximum number of infected cows that occurred in the
United States, said he has "absolutely no confidence in USDA tests before
one year ago" because of the agency's reluctance to retest the Texas cow
that initially tested positive.

USDA officials finally retested the cow and confirmed it was infected seven
months later, but only at the insistence of the agency's inspector general.

"Everything they did on the Texas cow makes everything USDA did before 2005
suspect," Brown said. ...snip...end


http://www.upi.com/ConsumerHealthDaily/ ... 5557-1284r


AND NOT TO FORGET what the OIG has said time and time again over the years;


http://www.usda.gov/oig/webdocs/50601-10-KC.pdf


03-025IF 03-025IF-631 Linda A. Detwiler [PDF]

http://www.fsis.usda.gov/OPPDE/Comments ... IF-631.pdf

Specified Risk Materials (SRMs)

I am in full support of the interim final rule which prohibits SRMs from

being included in food for human consumption. In addition to the list of

tissues published in this rule, I am requesting that additional tissues be

added to the list. These would include dura

("sheath") covering the spinal cord and the ENTIRE INTESTINE (from pylorus

to rectum). The scientific justification is provided below. THESE SRMs

should also be prohibited from ANY FDA regulated food or product intended

for human consumption, including but not limited to flavorings, extracts,

etc. ...

Dr. Linda Detwiler comments in full;

http://www.fsis.usda.gov/OPPDE/Comments ... IF-634.pdf


[Docket No. 03-025IFA] FSIS Prohibition of the Use of Specified Risk
Materials for Human Food and Requirement for the Disposition of
Non-Ambulatory Disabled Cattle

http://www.fda.gov/ohrms/dockets/docket ... -vol45.pdf

http://www.fda.gov/ohrms/dockets/docket ... -vol40.pdf

THE SEVEN 1/2 SCIENTIST REPORT *** ;-)

http://www.fda.gov/ohrms/dockets/docket ... tach-1.pdf

https://web01.aphis.usda.gov/regpublic. ... enDocument

http://www.fda.gov/ohrms/dockets/docket ... -vol35.pdf


Subject: SCRAPIE and CWD USA UPDATE July 19, 2006
Date: July 19, 2006 at 12:06 pm PST
SCRAPIE USA UPDATE MAY 31, 2006


Infected and Source Flocks

As of May 31, 2006, there were 93 scrapie infected and source flocks (Figure 3). There were 12 new infected and source flocks reported in May (Figure 4) with a total of 67 flocks reported for FY 2006 (Figure 5). The total infected and source flocks that have been released in FY 2006 are 53 (Figure 6), with 7 flocks released in May. The ratio of infected and source flocks released to newly infected and source flocks for FY 2006 = 0.79 : 1. In addition, as of May 31, 2006, 216 scrapie cases have been confirmed and reported by the National Veterinary Services Laboratories (NVSL), of which 33 were RSSS cases (Figure 7). This includes 33 newly confirmed cases in May 2006 (Figure 8). Eighteen cases of scrapie in goats have been reported since 1990 (Figure 9). The last goat case was reported in March 2006. New infected flocks, source flocks, and flocks released for FY 2006 are depicted in Chart 3. New infected and source statuses from 1997 to 2006 are depicted in Chart 4.

snip...

Scrapie Testing

In FY 2006, 26,185 animals have been tested for scrapie : 22,634 RSSS*; 2063 regulatory field cases; 61 necropsy validations, 5 rectal biopsy and 1427 regulatory third eyelid biopsies (Chart 9). ...

snip...END

http://www.aphis.usda.gov/vs/nahps/scra ... eport.html




CWD MAP

NOTICE CWD creeping its way to TEXAS, literally to it's border. ...

http://www.aphis.usda.gov/vs/nahps/cwd/ ... ies_lg.jpg




THEN NOTICE CWD sample along that border in TEXAS, Three Year Summary of Hunter-Kill CWD sampling as of 31 August 2005 of only 191 samples, then compare to the other sample locations ;


http://www.tahc.state.tx.us/animal_heal ... ug2005.pdf




THREE NEW CASES OF CWD were announced in this same location this month ;


FOR IMMEDIATE RELEASE, JULY 7, 2006:

3 SOUTHERN NEW MEXICO DEER TEST POSITIVE FOR CHRONIC WASTING DISEASE

SANTA FE - Three deer in southern New Mexico have tested positive for chronic wasting disease, bringing the total number of confirmed CWD-infected deer in the state to 15 since the first infected deer was discovered in 2002.

The Department received test results Wednesday from the state Veterinary Diagnostic Services laboratory in Albuquerque that two wild deer captured near the White Sands Missile Range headquarters east of Las Cruces had tested positive for chronic wasting disease. A third wild deer captured in the small community of Timberon in the southern Sacramento Mountains also tested positive for the disease.

The discoveries of the infected deer were part of the Department's ongoing efforts to monitor the disease, which to date has been confined to the southern Sacramento Mountains southeast of Cloudcroft and areas surrounding the Organ Mountains near Las Cruces. Two wild elk from the southern Sacramento Mountains tested positive for the disease in December 2005.

Chronic wasting disease is a fatal neurological illness that afflicts deer, elk and moose. There is no evidence of CWD being transmitted to humans or livestock. The disease causes animals to become emaciated, display abnormal behavior and lose control of bodily functions. To date, it has been found in captive and wild deer, elk and moose in eight states and two Canadian provinces.

For more information about CWD in New Mexico and how hunters can assist in research and prevention, please visit the New Mexico Department of Game and Fish Web site, http://www.wildlife.state.nm.us . More information about CWD also can be found on the Chronic Wasting Disease Alliance site at http://www.cwd-info.org/ .

###


http://www.wildlife.state.nm.us/publica ... 707CWD.htm




SEE MAP NM

http://www.wildlife.state.nm.us/documen ... rolmap.pdf



STATE CWD INFORMATION

http://www.aphis.usda.gov/vs/nahps/cwd/ ... einfo.html



REPORT OF THE COMMITTEE ON SCRAPIE

Chair: Dr. Jim Logan, Cheyenne, WY

Vice Chair: Dr. Joe D. Ross, Sonora, TX

Dr. Deborah L. Brennan, MS; Dr. Beth Carlson, ND; Dr. John R. Clifford, DC; Dr. Thomas F. Conner, OH; Dr. Walter E. Cook, WY; Dr. Wayne E. Cunningham, CO; Dr. Jerry W. Diemer, TX; Dr. Anita J. Edmondson, CA; Dr. Dee Ellis, TX; Dr. Lisa A. Ferguson, MD; Dr. Keith R. Forbes, NY; Dr. R. David Glauer, OH; Dr. James R. Grady, CO; Dr. William L. Hartmann, MN; Dr. Carolyn Inch, CAN; Dr. Susan J. Keller, ND; Dr. Allen M. Knowles, TN; Dr. Thomas F. Linfield, MT; Dr. Michael R. Marshall, UT; Dr. Cheryl A. Miller, In; Dr. Brian V. Noland, CO; Dr. Charles Palmer, CA; Dr. Kristine R. Petrini, MN; Mr. Stan Potratz, IA; Mr. Paul E. Rodgers, CO; Dr. Joan D. Rowe, CA; Dr. Pamela L. Smith, IA; Dr. Diane L. Sutton, MD; Dr. Lynn Anne Tesar, SD; Dr. Delwin D. Wilmot, NE; Dr. Nora E. Wineland, CO; Dr. Cindy B. Wolf, MN.

The Committee met on November 9, 2005, from 8:00am until 11:55am, Hershey Lodge and Convention Center, Hershey, Pennsylvania. The meeting was called to order by Dr. Jim Logan, chair, with vice chairman Dr. Joe D. Ross attending. There were 74 people in attendance.

The Scrapie Program Update was provided by Dr. Diane Sutton, National Scrapie Program Coordinator, United States Department of Agriculture (USDA), Animal and Plant Health Inspection Services (APHIS), Veterinary Services (VS). The complete text of the Status Report is included in these Proceedings.

Dr. Patricia Meinhardt, USDA-APHIS-VS-National Veterinary Services Laboratory (NVSL) gave the Update on Genotyping Labs and Discrepancies in Results. NVSL conducts investigations into discrepancies on genotype testing results associated with the Scrapie Eradication Program. It is the policy of the Program to conduct a second genotype test at a second laboratory on certain individual animals. Occasionally, there are discrepancies in those results. The NVSL conducts follow-up on these situations through additional testing on additional samples from the field and archive samples from the testing laboratories.

For the period of time from January 1, 2005, until October 15, 2005, there were 23 instances of discrepancies in results from 35 flocks. Of those 23 instances, 14 were caused by laboratory error (paperwork or sample mix-up), 3 results from field error, 5 were not completely resolved, and 1 originated from the use of a non-approved laboratory for the first test. As a result of inconsistencies, one laboratory's certification was revoked by APHIS-VS.

To reduce/eliminate these problems, the Program has placed additional quality requirements on the testing laboratories: additional review of final reports, additional coding systems for testing operations, strict follow-up and reports to NVSL on corrective actions, dual data entry systems, and more frequent inspections.


snip...






http://www.usaha.org/committees/reports ... r-2005.pdf


:help:



TSS
 
Top